Clinigen Group PLC
LSE:CLIN

Watchlist Manager
Clinigen Group PLC Logo
Clinigen Group PLC
LSE:CLIN
Watchlist
Price: 925 GBX Market Closed
Market Cap: £1.2B

Operating Margin

10.6%
Current
No historical data
Comparison unavailable

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.6%
=
Operating Income
£85.4m
/
Revenue
£807.5m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
10.6%
=
Operating Income
GBX85.4m
/
Revenue
£807.5m

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Clinigen Group PLC
LSE:CLIN
1.2B GBP
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
230.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
160.7B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
82.9T KRW
Loading...
CH
Lonza Group AG
SIX:LONN
37.9B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.7B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
274.7B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.1B USD
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.6B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR
Loading...

Market Distribution

Higher than 96% of companies in United Kingdom
Percentile
96th
Based on 3 579 companies
96th percentile
10.6%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Clinigen Group PLC
Glance View

Clinigen Group PLC operates at the intersection of two pivotal sectors: pharmaceutical services and global supply. Founded in 2010, the company carved a niche for itself by navigating the intricate pathways of drug development and commercialization with precision. Clinigen's business model hinges on providing essential support to pharmaceutical and biotech companies, ensuring that life-saving medicines are distributed efficiently, even to the remotest parts of the world. At its core, Clinigen operates through two main segments: Unlicensed Medicines and Commercial Medicines. In the Unlicensed Medicines segment, Clinigen sources, develops, and supplies medications that haven't yet received formal approval in certain markets, often as a response to urgent or unmet patient needs. Their success largely rests on their ability to adapt quickly, driven by their deep knowledge of regulatory environments and robust logistics capabilities. In parallel, the Commercial Medicines segment acts as a critical growth driver for Clinigen. This arm involves the acquisition and licensing of niche pharmaceuticals, which the company then revitalizes, focusing on enhancing their market reach and operational efficiency. By capitalizing on these acquired products, Clinigen augments its revenue streams significantly. The company’s adeptness at identifying undervalued or underutilized drugs allows them to breathe new life into these assets, maximizing their commercial potential. The intricate dance between these segments illustrates Clinigen's strategic prowess. Their unique approach not only bolsters profitability but also underscores their commitment to making a tangible difference in the pharmaceutical landscape, by improving both availability and accessibility of crucial medications to those who need them most.

CLIN Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
10.6%
=
Operating Income
£85.4m
/
Revenue
£807.5m
How has Operating Margin changed over time?

Over the last 3 years, Clinigen Group PLC’s Operating Margin has decreased from 12% to 10.6%. During this period, it reached a low of 10.6% on Jan 31, 2022 and a high of 14.7% on Jun 30, 2020.

Back to Top